View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
September 26, 2013

NuVasive introduces Precept spinal system in Japan

Design, development and marketer of products for surgical treatment of spine disorders company NuVasive has introduced its Precept system in Japan, treating the first patients with posterior fixation system.

By admin-demo

precept

Design, development and marketer of products for surgical treatment of spine disorders company NuVasive has introduced its Precept system in Japan, treating the first patients with posterior fixation system.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The Precept system consists of a variety of polyaxial screws, reduction screws, offset connectors, rods, locking nuts, and transverse connectors.

The implant components can be rigidly locked into a variety of different configurations to suit the individual pathology and anatomical conditions of the patient.

Surgeon proctors, who will instruct upcoming Precept training courses, have started to schedule surgeries now that the new system is available.

In July, NuVasive obtained the Shonin approval for Precept system, which is a part of company’s Precept line of minimally disruptive posterior fixation solutions.

NuVasive chairman and CEO Alex Lukianov said the company has its sights set on changing spine surgery and improving patient outcomes in Japan.

"With the approval and launch of Precept, we can introduce Japanese surgeons to additional innovation within our comprehensive portfolio of procedurally integrated spine solutions," Lukianov said.

"With the approval and launch of Precept, we can introduce Japanese surgeons to additional innovation within our comprehensive portfolio of procedurally integrated spine solutions."

According to the company, Precept is a highly differentiated solution with advanced guide technology, superior rod insertion options, and multiple reduction capabilities.

It offers ease-of-use, in addition to advanced compression/distraction systems and efficient instrumentation that can result in better patient outcomes.

NuVasive executive vice-president of international Russell Powers said: "The initial reception in Japan has been fantastic, and I applaud all of the NuVasive teams who worked diligently to achieve this milestone."

In April, the company officially opened office in Tokyo, Japan, which is headed by Takaaki Tanaka, NuVasive executive vice-president of Asia Pacific.

According to GlobalData estimates, pedicle screw systems market in Japan was valued at $337.8m in 2012 and is expected to grow at a CAGR of 10.1% to reach $662m by 2019.


Image: The Precept system. Photo: courtesy of Marketwire.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network